{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":4,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":4,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"08c60bd9815f","filters":{"venue":"Core evidence"}},"results":[{"id":"W2044171598","doi":"10.2147/ce.s40698","title":"Ceftazidime–avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections","year":2014,"lang":"en","type":"review","venue":"Core evidence","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":167,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Shared Health","funders":"","keywords":"Ceftazidime/avibactam; Avibactam; Ceftazidime; Medicine; Pharmacology; Tolerability; Microbiology; Pseudomonas aeruginosa; Adverse effect; Biology","authors":[{"name":"Philippe Lagacé‐Wiens","is_ca":true},{"name":"Andrew Walkty","is_ca":true},{"name":"James A. Karlowsky","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1210561534628271,"gpt":0.4038837467701463,"spread":0.2828275933073192,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006654625,0.0004666894,0.001471828,0.0001099331,0.00006282454,0.00003336864,0.0004944192,0.0003412512,0.00008654302],"category_scores_gemma":[0.001214534,0.0003184862,0.0003982852,0.0002903562,0.0004067824,0.00003851376,0.00007714194,0.0001636422,0.000005151684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006433338,"about_ca_system_score_gemma":0.000530493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005833458,"about_ca_topic_score_gemma":0.00009371297,"domain_scores_codex":[0.9965745,0.001304736,0.0009766851,0.0006524748,0.0002172378,0.0002743166],"domain_scores_gemma":[0.9970358,0.0008150409,0.0009969808,0.0007891263,0.0002783182,0.00008473518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001568853,0.003533335,0.004269857,0.3650004,0.001395996,0.00007727457,0.0003850399,0.00001563196,0.1187405,0.0001150827,0.005704041,0.4991941],"study_design_scores_gemma":[0.0007403638,0.00378959,0.001503265,0.195329,0.00258512,0.00008274556,0.00001113298,0.000005646356,0.002818802,0.000007854241,0.7924533,0.0006731414],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05890362,0.9385971,0.00008619725,0.00005242753,0.0004576581,0.00179662,0.00009502832,0.000006146558,0.00000517192],"genre_scores_gemma":[0.01163218,0.9872072,0.0002935061,0.0001192672,0.0003381454,0.0001256986,0.0002076275,0.00003359687,0.00004275256],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7867493,"threshold_uncertainty_score":0.9999267,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1972864082","doi":"10.2147/ce.s42568","title":"An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies","year":2013,"lang":"en","type":"article","venue":"Core evidence","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Pharmacology; Leukemia; Lymphoma; Adverse effect; Venetoclax; Oncology; Cancer research; Immunology; Chronic lymphocytic leukemia","authors":[{"name":"Carolyn A. Goard","is_ca":true},{"name":"Aaron D. Schimmer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07430101011301232,"gpt":0.3242971822992617,"spread":0.2499961721862494,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002658374,0.0000981915,0.0001950862,0.00001933973,0.00001920471,0.000006247245,0.0002024657,0.00007048441,0.00006988938],"category_scores_gemma":[0.0001585124,0.00005513369,0.00008872261,0.0001055961,0.00007997737,0.00001085501,0.00001346299,0.0000216789,0.000004167325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001093413,"about_ca_system_score_gemma":0.00005948175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006168081,"about_ca_topic_score_gemma":0.00001123881,"domain_scores_codex":[0.9991848,0.0001079802,0.0002707262,0.0001887056,0.0001409132,0.0001068499],"domain_scores_gemma":[0.9992157,0.00008084899,0.000137742,0.0004171544,0.0001218167,0.00002678162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00005507541,0.0002454056,0.01060397,0.001375767,0.00001138818,0.000005455354,0.0001085036,0.00007139411,0.973084,0.0007373921,0.0004043573,0.01329728],"study_design_scores_gemma":[0.0005491564,0.00587065,0.0764365,0.0203306,0.00010268,0.00003901111,0.0001789348,0.001358784,0.8906724,0.0009773994,0.00312677,0.0003570678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8770779,0.1213884,0.0004362898,0.0004529028,0.00003507374,0.0005798211,0.000001581487,0.00000321272,0.00002486384],"genre_scores_gemma":[0.9240089,0.07508575,0.0005077121,0.0002474051,0.00002266292,0.00008212469,0.00001069626,0.000004082785,0.00003067455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08241156,"threshold_uncertainty_score":0.2248287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2793091729","doi":"10.2147/ce.s133661","title":"Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis","year":2018,"lang":"en","type":"review","venue":"Core evidence","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University; University of British Columbia","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Dermatology","authors":[{"name":"Panteha Eshtiaghi","is_ca":true},{"name":"Melinda Gooderham","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1811466557996444,"gpt":0.4180229617493419,"spread":0.2368763059496976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004378794,0.0003510893,0.002165013,0.0001610672,0.0000399208,0.00000766704,0.0005191767,0.0002152947,0.0003561838],"category_scores_gemma":[0.001308347,0.0002054019,0.0006623595,0.0004614885,0.0003019664,0.0001879835,0.0000273649,0.0001543834,0.00006671585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000925436,"about_ca_system_score_gemma":0.001003915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002463516,"about_ca_topic_score_gemma":0.00001220725,"domain_scores_codex":[0.9971364,0.0007022772,0.001110378,0.0003829141,0.0004420956,0.0002259857],"domain_scores_gemma":[0.9967695,0.001083114,0.0006934155,0.001090651,0.000262698,0.0001005913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00003653354,0.0007095988,0.001836948,0.5663221,0.0001325016,0.0006127906,0.0001225381,1.420108e-7,5.859519e-7,0.00004227982,0.009329083,0.4208548],"study_design_scores_gemma":[0.0002675848,0.0006412698,0.003069791,0.7260646,0.002838357,0.0002744202,0.000009253567,0.000009390251,0.00001199325,0.00001230658,0.266647,0.0001540429],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005159703,0.9965956,0.000008026322,0.0004414108,0.000189759,0.002141356,0.00002567248,0.00001542271,0.00006683708],"genre_scores_gemma":[0.004021619,0.9946131,0.00006626608,0.0007568766,0.0001394317,0.0002690756,0.00005853247,0.00001988682,0.00005521911],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4207008,"threshold_uncertainty_score":0.8376048,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2060750200","doi":"10.2147/ce.s7031","title":"Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson’s disease","year":2009,"lang":"en","type":"article","venue":"Core evidence","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Entacapone; Dyskinesia; Levodopa; Carbidopa; Parkinson's disease; Medicine; Tolerability; Ropinirole; Adverse effect; Aromatic L-amino acid decarboxylase; Dopamine; Pramipexole; Pharmacology; Catechol-O-methyl transferase; Anesthesia; Internal medicine; Disease; Chemistry","authors":[{"name":"Markos Poulopoulos","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1886964160948864,"gpt":0.3931705350588015,"spread":0.2044741189639151,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004253005,0.0003207806,0.0004149272,0.00009037793,0.0001587151,0.00003657305,0.0003952639,0.00006218215,0.00005372215],"category_scores_gemma":[0.0009604202,0.0001722164,0.0002946149,0.0003824774,0.00008704732,0.0002128038,0.00002268717,0.0001036435,0.00004035351],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002591994,"about_ca_system_score_gemma":0.0003018937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006355194,"about_ca_topic_score_gemma":0.00005001923,"domain_scores_codex":[0.9979407,0.0001446346,0.0003914789,0.0005292944,0.0005688157,0.0004250347],"domain_scores_gemma":[0.9971467,0.001344272,0.0001865236,0.0009476536,0.0001376442,0.0002372412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03629986,0.01633908,0.7153715,0.001755297,0.0008189988,0.002345126,0.01593197,0.0004911895,0.02072582,0.007430143,0.01871849,0.1637726],"study_design_scores_gemma":[0.003925473,0.003567373,0.9334285,0.00329585,0.001356827,0.0000555826,0.000317006,0.001609912,0.003269149,0.001252828,0.04754224,0.0003792915],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9401821,0.05054538,0.0001556899,0.006011162,0.0001899426,0.00274519,0.00005746493,0.00003735861,0.000075741],"genre_scores_gemma":[0.9916124,0.005701793,0.000251644,0.001089306,0.0001977576,0.0004861028,0.0000218015,0.00001952994,0.0006197171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.218057,"threshold_uncertainty_score":0.7022781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}